查看完整行情页>>

|

货币单位:美元(USD)

Aerie Pharmaceuticals, Inc.

Aerie Pharmaceuticals, Inc. (aeri)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
证券代码:aeri 公司名称:Aerie Pharmaceuticals, Inc. 公司中文简称:
公司简介:

Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX.

公司网站:
http://www.aeriepharma.com
公司地址:
6201 South Freeway Forth Worth